Beilstein J. Org. Chem.2021,17, 1360–1373, doi:10.3762/bjoc.17.95
) encapsidates the dsRNA of 563 bp, are shown to silence the WSSV glycoprotein VP28 (dsRNAvp28). In experimental challenges in vivo, the VLPs- dsRNAvp28 protect shrimp against WSSV up to 40% by oral administration and 100% by IM. The novel research demonstrates that plantVLPs, which avoid zoonosis, can be
applied to pathogen control in shrimp and also other organisms, widening the application window in nanomedicine.
Keywords: antiviral therapy; CCMV; oral administration; P. vannamei; plantVLPs; RNAi; VP28; white spot syndrome virus; Introduction
The white spot syndrome virus (WSSV) is recognized as one
PDF
Graphical Abstract
Figure 1:
Analysis of the VLP-dsRNAvp28 assembly by electrophoresis mobility shift assay (EMSA) in a 1% nativ...